The deal marks another notable transaction by a Taiwanese insurer following Fubon Life’s over $1bn sale of a private market portfolio.
2 min read · 29 May 2025
Nearly 45% of companies within single-asset CVs had an implied TEV greater than $2bn last year reflecting minority interest or strip sales for larger companies being used in these deals.
2 min read · 29 May 2025
Flexstone Partners Asia Selection III is now fully subscribed for by the firm’s majority shareholder, Natixis Investment Managers, and will invest its capital over the coming years, chief executive Eric Deram tells Secondaries Investor.
3 min read · 29 May 2025
Part of the portfolio, which includes exposure to Advent International and Antin Infrastructure Partners, was picked up by Hamilton Lane.
2 min read · 28 May 2025
With private equity portfolio sales proliferating, here’s why UK multi-family office Stonehage Fleming is an active secondaries buyer and Australian state fund QIC is not.
5 min read · 22 May 2025
The new evergreen vehicle will join the firm’s four active 40 Act funds targeting wealthy individual investors in the US.
2 min read · 21 May 2025
In spite of shockwaves from Trump’s on-again-off-again trade war, the secondaries industry is gearing up for yet another record year.
10 min read · 20 May 2025
French investment firm Peugeot Invest is offloading 35 PE funds to rebalance its portfolio.
2 min read · 19 May 2025
With peers facing substantial portfolio challenges, the $30bn endowment is urging restraint in what its leaders say is an environment for endowments akin to 2008’s financial crisis.
3 min read · 19 May 2025
Without new capital coming in, the firm is considering an extensive continuation fund process that would extend its ability to make new investments.
5 min read · 15 May 2025